Mölnlycke

Mölnlycke is a global medical solutions brand specialising in advanced wound care and surgical products designed to improve healing outcomes, enhance patient comfort, and support efficient clinical workflows. With a strong focus on evidence-based innovation, Mölnlycke develops products that help reduce wound trauma, minimise pain during dressing changes, and support consistent, high-quality care across healthcare settings.

The brand is best known for its advanced wound care portfolio, which includes soft silicone dressings, absorbent foam technologies, and gentle fixation solutions. These products are widely used in hospitals, community care, and specialist wound clinics for managing acute, chronic, and complex wounds such as pressure injuries, leg ulcers, surgical wounds, burns, and skin tears.

At the core of Mölnlycke’s innovation is its Safetac® technology, a soft silicone adhesive designed to gently adhere to surrounding skin without sticking to the wound bed. This helps protect fragile tissue, reduce pain and trauma during dressing changes, and support a more comfortable healing experience for patients.

The Mölnlycke portfolio is developed by Mölnlycke Health Care, a leading global provider of medical products focused on advancing clinical care through innovation and sustainability.

The product range includes well-known solutions such as Mepilex, Mepitel, Mepitac, Mepore, Mesorb, and Mextra, each designed to address different levels of exudate, wound types, and clinical needs.

Overall, Mölnlycke is trusted by healthcare professionals worldwide for delivering gentle, reliable, and clinically effective wound care solutions that prioritise both patient wellbeing and practical usability in everyday healthcare environments.